GSK CEO to discuss China scandal at quarterly results, Reuters reports
GlaxoSmithKline CEO Andrew Witty will detail what action the drug-maker is taking in response to allegations of bribery against it in China when he presents the company's quarterly results on Wednesday, sources say, reports Reuters.